Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Novel anti-HCV agents claimed by the Italian researchers

Feb. 22, 2005

Novel anti-hepatitis C virus agents developed by Anadys researchers

Feb. 21, 2005

Enrollment open in phase II study of Virostat for hepatitis C

Feb. 21, 2005

Enrollment completed in phase II HCV study of Albuferon

Feb. 18, 2005

OctoPlus and Biolex to jointly develop controlled-release alfa interferon

Feb. 18, 2005

Phase I program begins for HCV-796

Feb. 17, 2005

FDA raises questions over Probactrix IND

Feb. 10, 2005

Aston University team presents novel CCK1, CCK2 modulators

Feb. 9, 2005

Fendrix hepatitis B vaccine approved in Europe

Feb. 9, 2005

Celecoxib shows promise in the prevention of intraabdominal adhesions

Feb. 9, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...